AgendaSaturday, December 7, 2024

7:30 AM - 8:00 AM

Registration and Breakfast

8:00 AM - 8:10 AM

Opening Remarks by Moderator

Presented by Joseph F. Goldberg, MD

8:10 AM - 9:10 AM

Innovative Approaches for PTSD: Unraveling Pathophysiology and New Treatment Frontiers

Presented by Lori L. Davis, MD

In this session, review the latest research exploring the underlying pathophysiology of PTSD and explore clinical evidence for approved and emerging treatments.

9:10 AM - 9:20 AM

Break

9:20 AM - 10:20 AM

Sutures, Psych, and Sobriety: Tying Together Psychiatric Post-op Support for At-risk Patients

Presented by Michael Sprintz, DO, DFASAM

Patients with SUDS have unique concerns about pain management and relapse when they are faced with surgery. Participants will gain practical insights on interprofessional communication strategies, advocating for their patients, and managing medications for SUDs throughout the surgical process.

10:20 AM - 10:30 AM

Wellness Break

10:30 AM - 11:30 AM

A Pharmacologic View of Tardive Dyskinesia: Pathology and Treatment

Presented by Greg W. Mattingly, MD

This session will revisit the mechanism of action, molecular differences, and PK/PD of VMAT2 inhibitors. Clinical considerations for safety and efficacy in older populations as they relate to dosing/titration schedules in special populations with age-related changes in body composition, metabolism, and comorbidities will be discussed.

11:30 AM - 11:35 AM

Break

11:35 AM - 12:35 PM

Clusters of Concerns: Neurobiology and Treatment of Psychiatric Disorder Comorbidities

Presented by Vladimir Maletic, MD, MS

In this session, we will dive into the neurobiological roots of psychiatric disorder comorbidities, discuss the complexities of comorbidities in differential diagnosis, and outline advanced strategies for managing psychiatric comorbidities.

12:35 PM - 12:55 PM

Break & Lunch for in-person attendees

12:55 PM - 1:55 PM

Iterative Psychopharmacology: How to Decide What to Do When First or Second Interventions Fail

Presented by Joseph F. Goldberg, MD

This interactive session offers a systematic approach to making decisions for patient care for steps beyond first and second line treatment options. This approach considers variables that are important to patients, to HCPs, and what the data tell us to arrive at our next shared decision for optimized patient care.

1:55 PM - 2:00 PM

Wellness Break

2:00 PM - 4:20 PM

Head to Toe Pain Management: Identifying and Managing Patients with Pain to Minimize Adverse Opioid Outcomes

Presented by Michael Sprintz, DO, DFASAM

This comprehensive, 2.5-credit hour session covers opioid use disorder and pain management from head to toe, with a focus on areas of interest to psychiatry HCPs. Through expert-led discussions on where pain assessment, and management options cross the psychiatry space, and in addition to opioid use disorder identification and management, attendees will gain appreciation for and understanding of the biopsychosocial model of pain and addiction, helping to reinforce clinical strategies that will promote safe, effective, patient-centered care. This session fulfills 2.5 hours of DEA MATE Act requirements.

4:20 PM - 4:30 PM

Closing Remarks by Moderator

Presented by Joseph F. Goldberg, MD